Presentation is loading. Please wait.

Presentation is loading. Please wait.

ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS.

Similar presentations


Presentation on theme: "ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS."— Presentation transcript:

1 ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

2 Increasingly used in abdomen and pelvis since the last decade DWI  ADC(Apparent Diffusion Coefficient)  Cellularity Increased Cellularity  Impeded diffusion INTRODUCTION

3 REVIEW OF LITERATURE Role of diffusion weighted imaging in the diagnosis of gynecological diseases : Tomohiro Namimoto,Kazuo Awai,Takeshi Nakaura,Yumi Yanaga : European Society of Radiology 2008

4 Important cancer biomarker Aids in superior lesion characterization, tumor staging, treatment planning, and disease follow-up of gynaecological tumors Help predict and assess treatment response earlier than other techniques Can detect residual / recurrent tumor REVIEW OF LITERATURE Diffusion-weighted Imaging of Gynecologic Tumors: Diagnostic Pearls and Potential Pitfalls : Sunita Dhanda, et al Radiographics 2014 :34:1393–1416

5 To assess role of Diffusion weighted imaging (DWI) in differentiating benign from malignant lesions of uterus and cervix AIM

6 24 patients with uterine and cervical lesions 15 control patients with normal uterus and cervix DWI with b value 800 as a part of routine MR imaging on 1.5T MRI Apparent diffusion coefficient (ADC) calculated and correlated with histopathology Inclusion criteria: Patients with lesions of uterus and cervix who have undergone MRI and who have HPE follow up Exclusion criteria: Patients who have contraindications to MR imaging and who have no HPE follow up MATERIALS AND METHODS

7 Name Age Hospital No Date Of MRI Study Clinical History Previous USG,CT,MRI findings Findings at MRI with special emphasis on DWI Clinical Follow Up HPE Diagnosis PROFORMA

8 PATHOLOGIES (n=2) (n=12) (n=5)

9 CARCINOMA ENDOMETRIUM T2 WI ADC : 0.648x10 -3 mm 2 /s DWI ADC F/65, Post menopausal bleeding

10 CARCINOMA ENDOMETRIUM ADC 0.712 x10 -3 mm 2 /s T2 WI DWI ADC F/52, Menorrhagia

11 ADC :Normal Endometrium S.NO.CONTROL ADC VALUES (X 10 -3 mm 2 /s) 1.1.42 2.1.29 3.1.33 4.1.43 5.1.59 6.1.45 7.1.34 8.1.46 9.1.42 10.1.42 11.1.47 12.1.59 13.1.42 14.1.49 15.1.41 S.NoADC VALUES (X 10 -3 mm 2 /s) 1.1.29 2.0.712 3.0.619 4.0.94 5.0.981 Range: 1.29 to 1.59 x 10 -3 mm 2 /s Mean ADC : 1.44 x 10 -3 mm 2 /s Range :0.619 to 1.29 x 10 -3 mm 2 /s Mean ADC : 0.88 x 10 -3 mm 2 /s ADC :Ca Endometrium

12 NPAR TESTS MANN-WHITNEY TEST RANKS TEST STATISTICS a. Grouping Variable: ANN b. Not corrected for ties

13 CARCINOMA CERVIX T2 WI ADC: 0.923x10 -3 mm 2 /s DWI ADC F/57Post menopausal bleeding

14 CARCINOMA CERVIX ADC 0.977 x 10 3 mm 2 /s T2 WI DWI ADC F/57,White discharge

15 ADC values of normal cervix S.NoCONTROL ADC VALUES X 10 -3 mm 2 /S 11.35 2 1.37 3 1.40 4 1.56 5 1.42 6 1.46 7 1.37 8 1.36 9 1.34 10 1.36 11 1.43 12 1.37 13 1.36 14 1.32 15 1.37 S.NoADC VALUES X 10 -3 mm 2 /S 10.618 21.104 30.886 41.012 50.977 Range :1.32 to 1.56 x10 -3 mm 2 /s Mean ADC : 1.39 x10 -3 mm 2 /s Range :0.618 to 1.012 x10 -3 mm 2 /s Mean ADC :0.909 x10 -3 mm 2 /s ADC values of Carcinoma cervix

16 NPAR TESTS MANN-WHITNEY TEST RANKS TEST STATISTICS b. Not corrected for ties. a. Grouping Variable: ANN

17 LEIOMYOMA T2 WI ADC: 1.616 x10 -3 mm 2 /s DWI ADC F/43,Menorrhagia, dysmenorrhoea

18 LEIOMYOMAS T2 WI ADC: 1.256 x10 -3 mm 2 /s DWI ADC F/43 Menorrhagia

19 ADC values of normal myometrium S.NOCONTROL ADC VALUES X 10 -3 mm 2 /s 1.1.57 2.1.39 3.1.64 4.1.68 5.1.51 6.1.54 7.1.46 8.1.54 9.1.56 10.1.52 11.1.42 12.1.54 13.1.54 14.1.53 15.1.52 Range: 1.39 to 1.68 x10 -3 mm 2 /s Mean ADC : 1.53 x10 -3 mm 2 /s S.NO.ADC VALUES X 10 -3 mm 2 /s 12.27 21.77 31.59 41.53 51.54 61.206 71.828 82.059 91.616 101.256 112.1 121.41 ADC values of Leiomyoma Range: 1.24 to 2.27 x10 -3 mm 2 /s Mean ADC : 1.67x10 -3 mm 2 /s

20 STATISTICAL ANALYSIS :T-TEST

21 Independent Samples Test Levene's Test for Equality of Variancest-test for Equality of Means FSig.tdf Sig. (2- tailed) Mean Differe nce Std. Error Differe nce 95% Confidence Interval of the Difference LowerUpper VALUESEqual variances assumed 20.595.000-1.67125.107-.14858.08894-.33176.03459 Equal variances not assumed -1.50311.834.159-.14858.09888-.36436.06720 STATISTICAL ANALYSIS (Cont…)

22 ADENOMYOSIS ADC values of adenomyosis : 1.458 x 10 -3 mm/s and 1.506 x 10 -3 mm/s T2 WI DWIADC F/40 Dysmenorrhea, ADC: 1.506 x10 -3 mm 2 /s

23 Significant reduction in ADC values of malignant lesions as compared to benign ones Mean ADC of Ca Endometrium (0.88 x10 -3 mm 2 /s ) < Mean ADC of normal Endometrium (1.44 x10 -3 mm 2 /s ) Mean ADC of Ca Cervix (0.9 x10 -3 mm 2 /s) < Mean ADC of normal Cervix (1.39 x10 -3 mm 2 /s ) RESULTS

24 CONCLUSION DWI with quantification of ADC values plays a major role in distinguishing benign and malignant lesions DWI should be part of routine MR protocol when imaging the uterus and cervix

25 THANK YOU..


Download ppt "ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS."

Similar presentations


Ads by Google